Quadrant Private Wealth Management
VRTX icon

Quadrant Private Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Quadrant Private Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$274K Buy
524
+35
+7% +$17.9K 0.04% 252
2026
Q2 		$243K Buy
+489
New +$217K 0.05% 144
2020
Q3 		– Sell
-698
Closed -$203K – 187
2020
Q2 		$203K Sell
698
-628
-47% -$170K 0.12% 166
2020
Q1 		$316K Buy
+1,326
New +$304K 0.26% 88

Other funds holding VRTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Quadrant Private Wealth Management's VRTX Position: Q3 2026 in Review

Quadrant Private Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 7.2% in Q3 2026, buying an estimated $17.9K and bringing the position to 524 shares worth $274K. The position accounts for 0.04% of the portfolio, ranked #252.

Quadrant Private Wealth Management first reported a position in VRTX in Q1 2020 and has held it in 4 quarters since. The position peaked at $316K in Q1 2020. 992 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Quadrant Private Wealth Management held 524 shares of Vertex Pharmaceuticals worth $274K as of Q3 2026.
  • Quadrant Private Wealth Management bought 35 Vertex Pharmaceuticals shares in Q3 2026, an estimated $17.9K.
  • Vertex Pharmaceuticals made up 0.04% of Quadrant Private Wealth Management's portfolio in Q3 2026, its #252 holding.
  • Quadrant Private Wealth Management first reported a position in Vertex Pharmaceuticals in Q1 2020 and has held it in 4 quarters since.
  • Quadrant Private Wealth Management's Vertex Pharmaceuticals position peaked at $316K in Q1 2020.
  • 992 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Quadrant Private Wealth Management's 13F filing for Q3 2026, filed 4 Nov 2026.